Gene context drift identifies drug targets to mitigate cancer treatment resistance.
Jassim A, Nimmervoll BV, Terranova S, Nathan E, Hu L, Taylor JT, Masih KE, Ruff L, Duarte M, Cooper E, Katyal G, Akhbari M, Gilbertson RJ, Coleman JC, Toker JS, Terhune C, Balmus G, Jackson SP, Liu H, Jiang T, Taylor MD, Hua K, Abraham JE, Filbin MG, Hill A, Patrizi A, Dani N, Regev A, Lehtinen MK, Gilbertson RJ.
Jassim A, et al. Among authors: jiang t.
Cancer Cell. 2025 Jun 20:S1535-6108(25)00255-7. doi: 10.1016/j.ccell.2025.06.005. Online ahead of print.
Cancer Cell. 2025.
PMID: 40578362